Bioelectronics Corp (BIEL)

[thesmalls]

More about liability. If there is a major adverse effect during clinical trials/early adoption - it cuts MUCH deeper with a major pharma that has earnings/assets vs a company struggling to survive. Once established - big Pharma can leverage their distribution agreements/supply chain to drive down mfg costs and ramp up adoption. They will pay a premium on the back end to protect (minimize)themselves from liability on the front end. Thank the bottom dweller attorneys for that reality and your elected officials tht REFUSE to discuss, let alone pass, real tort reform. Still one of the biggest costs/barriers to entry in medical field (nd mfg in general).